CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

Andrei Szilagyi - Medical Cannabis Research Engine

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Andrei Szilagyi

OPENALEX: A5031457888↗ORCID: 0009-0009-4734-4509↗

Affiliations

Organizations

Grigore T. Popa University of Medicine and Pharmacyauthorship · RO

Public evidence

6 connected articles

MRI-Based Radiomics Reveals Cannabinoid-Associated Tumor Phenotypes in a Murine Breast Cancer Model.2026 · Europe PMC Safety and Efficacy Assessment of Cannabis Plant Compared to Atorvastatin for Lipid Lowering in Diabetic and Obese Wistar Male Rats2026 · PubMed Central Open Access Therapeutic relevance of an EU-GMP certified <i>Cannabis sativa</i> L. strain in a dual <i>in vivo</i> model of cognitive impairment and chronic neuropathic pain.2026 · Europe PMC Evaluation of long-term safety profile of an EU-GMP certified <i>Cannabis sativa</i> L. strain in a naturally aging preclinical model.2025 · Europe PMC Exploring the impact of chronic intermittent EU-GMP certified Cannabis sativa L. therapy and its relevance in a rat model of aging.2025 · Europe PMC Acute Toxicity and Pharmacokinetic Profile of an EU-GMP-Certified <i>Cannabis sativa</i> L. in Rodents.2023 · PubMed Central Open Access

Matched by exact identifiers only. Profile data: Corpus/OpenAlex.